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Summary The tumour cell lines U937A and L929 form large, loosely packed colonies in vitro and can be
killed by the cytokine tumour necrosis factor (TNF). In contrast, their TNF-resistant mutants U937A/R and
L929/R form tightly packed colonies. Since cells which form loose colonies have increased metastatic potential
it is important to understand the factors governing colonial morphology. To this end, we have compared the
extracellular matrices (ECMs) of the 'loose' lines, U937A and L929 with their 'tight' mutants. By immuno-
fluorescence, a polyvalent anti-U937A serum revealed a fibrillar network in the ECMs of the 'loose' lines
which was absent in the 'tight'. On Western blotting of ECMs the antiserum detected an additional 300 kDa
protein in the 'loose' lines which was subsequently shown to be cellular fibronectin. The four lines secreted
comparable amounts of fibronectin and this was qualitatively indistinguishable between 'loose' and 'tight' cells
by peptide mapping or lectin binding. It is concluded that the differences in colonial morphology are due to
the 'tight' mutants' inability to incorporate fibronectin into the ECM.
Among its many properties the cytokine tumour necrosis
factor (TNF) can cause necrosis of some transplantable
tumours in vivo and cytolysis of certain tumour cell lines in
vitro (Carswell et al., 1975). Approximately one-quarter of
tumour cell lines can be killed by TNF in vitro but even the
TNF-susceptible lines can give rise to TNF-resistant mutants
after chronic exposure to TNF (Matthews & Neale, 1987).
Development of resistance to TNF is usually not due to
receptor loss and in the cell lines we have studied appears to
be failure to transmit the lytic message (Matthews & Neale,
1989).
Previously we have shown that when the TNF-susceptible
tumour cell lines L929 and U937A are exposed to TNF, the
resulting TNF-resistant mutants adhere more strongly to
plastic and are less flattened and motile. Furthermore the
TNF-susceptible cells form large, loosely packed ('loose')
colonies whereas their TNF-resistant sublines form smaller,
more tightly packed ('tight') colonies (Matthews & Neale,
1989). Similar colonial variants of tumour cell lines have
been described previously and are of more than theoretical
interest as 'loose' colony variants of murine melanoma cells
have greater metastatic potential than the 'tight' variants
(Clark & Sidebottom, 1984; Clark et al., 1987). Similarly, we
have found that 'loose' U937A cells are more invasive and
metastatic in vivo than 'tight' U937A/R cells (Neale et al.,
1990). Therefore understanding the factors which govern col-
onial morphology will give insight into the metastatic pro-
cess.
Colonial morphology is dependent upon the adhesive and
motile properties of the cell which in turn are related to the
interaction of the cell with the extracellular matrix (ECM). In
this paper we have compared the extracellular matrices of
TNF-susceptible tumour cell lines (U937A and L929) with
their resistant sublines (U937A/R and L929/R).
Materials and methods
Tumour cell lines
The L929, L929/R, U937A and U937A/R cells used in this
study are uncloned populations as described previously
(Matthews & Neale, 1989) except that in the interim the
U937A/R cells had been subjected to even greater selective
pressure by occasional pulsing with human rTNF at 2.5 g
ml-'. TNF-resistant lines were unaffected by this high TNF
concentration but >99% of L929 and U937A cells were
killed by 2 ngml-' TNF.
The plastic-adherent U937A cells originally rose spontan-
eously in culture as a small proportion of conventional non-
adherent U937 cells. We believed the adherent population to
be U937 derivatives because of reactivity in Southern blots
with the Blur 8, human-specific probe and in Western blots
with an antiserum to non-adherent U937 cells. In more
recent studies, certain murine specific antisera have reacted
with the plastic adherent but not with the non-adherent U937
cells suggesting that the plastic adherent cells may be human/
mouse hybrids.
Radiolabelling ofcellular proteins
Cells were plated at 10 ml-' in ml growth medium (5%
fetal calf serum in RPMI1640) in 1.5 cm wells of cluster
plates. After 2 days at 37'C, the cells were washed with
isotonic, phosphate buffered saline, pH 7.3 (PBS) and incu-
bated for a further 16 h in 0.5 ml methionine free, Eagle's
minimum essential medium (Imperial Labs., Andover) with
125 jsCi ml-' "5-methionine (>800 Ci mmol-', Amersham,
Little Chalfont) with or without 5% fetal calf serum (FCS)
as required.
Antisera
Rabbit antiserum against an ultrasonicate of U937A cells
was raised as described elsewhere (Neale et al., 1990). Rabbit
antisera against laminin from the Engelbreth-Holm-Swarm
tumour were purchased from Chemicon International Inc.
(London) or Eurodiagnostics (Reading). Rabbit anti-human
plasma fibronectin was from Dako Ltd (High Wycombe).
Mouse IgM monoclonal anti-cellular fibronectin and alkaline
phosphatase or fluorescein conjugated secondary antibodies
were from Sigma Chemical Co. Ltd (Poole). The monoclonal
anti-cellular fibronector antibody (F-6140) works well on
immunofluorescence but not on Western blotting.
Other reagents
Laminin, bovine plasma fibronectin, chromatographically
purified collagenase, TPCK-treated trypsin and fluorescein-
labelled wheat germ agglutinin, gelatin-agarose beads and
Staph. aureus V8 protease were purchased from Sigma.
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Immunofluorescence
Confluent cultures of cells in 35 mm Petri dishes were fixed
for 5 min in 3.7% formaldehyde, incubated for 20 min with
1/200 primary antibody, washed x 10 with PBS and finally
incubated with 1/200 fluorescein conjugated anti-rabbit IgG.
After a further 10 washes with PBS the cells were examined
with a Leitz incident-light, fluorescent microscope. The anti-
sera were diluted in PBS containing 5% FCS.
ECM isolation
Cells (2.5 x l05) were cultured for 3 days in 0.5 ml growth
medium in 1.5 cm wells of cluster plates. After washing x 3
with PBS, cells were treated in turn with 0.5% triton X-100,
5 mg ml-' sodium deoxycholate, hypotonic salt and hyper-
tonic salt (Heremans et al., 1988). 'Loose' and 'tight' cells
were treated in parallel and their ECMs were solubilised by
adding 30 p1 loading buffer (2% SDS, 5% P-mercaptoetha-
nol, 10% glycerol). This was mixed with the ECMs by
repeated pipetting and the viscous mixtures were transferred
to 1.5 ml centrifuge tubes. Because of the bulky nature of the
matrix this resulted in final volumes of about 100p1 and the
appropriate amount of 10 x loading buffer was added to
give a final concentration of 2% SDS. If there were differ-
ences in volume between 'loose' and 'tight' preparations at
this stage then 1 x loading buffer was added to the lower
volume preparation to equalise volumes. Samples were boiled
for 3 min and centrifuged before applying 20pl amounts to
the gel.
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis
(SDS-PAGE) and Western blotting
Gels 0.8 mm thick were employed with a 5% stacking gel
and a 7.5% separating gel (Laemmli, 1970). After staining
with Coomassie blue, gels were dried down and autoradio-
graphed with Hyperfilm P max (Amersham). For Western
blotting gels were transferred to Hybond C membranes
(Amersham) in a Biorad Transblot apparatus using 30V/
7OmA for 7 h in 25 mM Tris, 192 mM glycine, 20% (v/v)
methanol buffer. The blots were treated for 2 x 15 min with
PBS containing 0.25% Tween 20 and 1% FCS (PBST-FCS)
to prevent non-spectific binding and then exposed to the
primary antibody diluted 1/200 in PBST-FCS for 16 h at
25°C. After 5 x 5 min washes with PBST, 1/1,000 dilution of
alkaline phosphatase-conjugated anti-rabbit IgG was added
for 4 h at 25°C. Colour development employed the method of
Blake et al. (1984).
Fibronectin purification and enzyme digestion
Supernatants (0.5 ml) from cells labelled as above were cen-
trifuged to remove debris and then added to 25gll gelatin-
agarose beads. After mixing for 30 min at 25°C the beads
were washed x 4 with PBS, x I with 0.5 M urea and x 1
with PBS. For SDS-PAGE, 70gl loading buffer was added
and the mixture boiled for 3 min. Alternatively, for peptide
mapping 20gll Staph. aureus V8 protease was added in 30gl
65 mM Tris, 0.5% SDS, pH 6.8 (Dahl & Grabel, 1988). After
30 min at 37°C, 50 gli 2 x loading buffer was added before
boiling for 3 min.
For binding of fibronectin to wheat germ agglutinin or
Ricinus communis RCA,20 (ricin) lectins established methods
were used (Neale et al., 1990).
Co-cultivation experiments
Volumes of 25 gil of TNF-susceptible and -resistant cells
(3 x 105 ml-') were carefully pipetted into a 35 mm Petri dish
to give two 'beads' about 8 mm apart. The dish was left
undisturbed for 4-6 h to allow the cells to adhere, carefully
washed to remove non-adherent cells and then flooded with
2 ml growth medium and incubated for 3 days.
Results
Differences between the ECMs of 'loose' and 'tight' cell lines
The initial observation of differences between the ECMs of
U937A and U937A/R cells arose from immunofluorescent
studies of Triton X-100 treated cells with a polyvalent anti-
serum raised against a whole cell extract of U937A. This
antiserum revealed a fibrillar network around 'loose' U937A
cells but not around 'tight' U937A/R cells (Figure la and b).
Under similar conditions, the network was also exhibited by
'loose' L929 cells but not by 'tight' L929/R cells. In all
subsequent experiments ECMs were additionally purified by
deoxycholate, hypo- and hypertonic salt treatment and these
preparations gave similar immunofluorescence patterns to
Figure 1.
The TNF resistant sublines used above were selected by
TNF treatment of the parental TNF-susceptible lines. As an
alternative susceptible cells can be cloned out in the absence
of TNF and although usually >90% of the colonies are
loose a minority are tight and on subculture these cells also
prove to be TNF-resistant and strongly adherent (Matthews
& Neale, 1989). Two of these 'tight' clones (U937A/T3 and
U937A/T4) were tested by immunofluorescence and also
found to lack the fibrillar network. These observations there-
fore show a close correlation between the production of this
network and the phenotype of TNF susceptibility/weak
adherence/loose colony formation.
Characterisation ofthefibrillar network
Treatment of the U937A ECM with 20gig ml-' protease-free
collagenase was without effect on the network as revealed by
immunofluorescence. However, brief trypsinisation complete-
ly abolished immunoreactivity. This suggests that the net-
work contains a non-collagenous protein and in an attempt
Figure I Immunofluorescene of (a) U937A and (b) U937A/R
cells with a polyvalent antiserum raised against U937A cells. The
cells were treated with 0.5% triton X-100 for 20min to remove
the bulk of the cytoplasmic and membrane proteins and then
fixed with 3.7% formaldehyde for 5 min before immunostaining.
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to identify it, ECMs of 'loose' and 'tight' cells were com-
pared by SDS-PAGE after mercaptoethanol reduction. On
Coomassie blue or silver staining the ECMs of U937A and
L929 had a characteristic pattern of bands which was lacking
in U937A/R and L929/R. The pattern comprised a major
band at about 300 kDa with a number of fainter and slightly
smaller bands and this pattern was most clearly seen after
Western blotting with the anti-U937A serum (Figure 2). A
clear difference in the expression of a 300 kDa protein could
also be seen after autoradiography of ECMs from 35S-meth-
ionine-labelled cells (Figure 3).
The high molecular weight is consistent with the protein
being either laminin or a high molecular weight form of
fibronectin. Laminin can be excluded on three counts. Firstly,
anti-laminin sera do not react with the protein on Western
blotting or with the fibrillar network on immunofluorescence.
Secondly, when laminin and the U937A network protein are
run side by side on SDS-PAGE, the major network protein
has intermediate mobility between the laminin A and B
chains. Finally, the polyvalent anti-U937A serum which re-
acts with the 300 kDa protein on Western blotting does not
react with laminin. However, several lines of evidence
indicate that the network protein is a high molecular weight
form of fibronectin. Firstly, anti-U937A serum reacts on
Western blots with the 220 kDa form of fibronectin from
mouse plasma. Secondly, on immunofluorescence, the net-
work is also revealed in L929 and U937A cultures but no in
L929/R or U937A/R by a polyclonal antibody to plasma
fibronectin (Figure 4). Thirdly, this polyclonal anti-
fibronectin reacts with a 300 kDa protein on Western blots of
ECMs from U937A and L929 but not with U937A/R and
L929/R ECMs. Finally, the 300 kDa protein was solubilised
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Figure 3 Autoradiographs of 35S-methionine labelled ECMs
from (a) U937A, (b) U937A/R, (c) L929 and (d) L929/R. A 7.5%
gel was used and the markers indicate molecular weight stan-
dards, with the values being given in kDa. All samples are the
ECM from IOs cells and were mercaptoethanol reduced before
electrophoresis.
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Figure 2 Western blots of ECMs of (a) U937A/R and (b)
U937A after probing with a polyvalent anti-U937A serum. A
7.5% gel was used and the markers indicate molecular weight
standards, with the values being given in kDa. Samples were
reduced before electrophoresis.
from L929 and U937A ECMs by incubation for 2 h at 37°C
with 1 M urea and found to bind to gelatin, as expected of a
fibronectin. These data suggest that the network protein is a
'cellular' form of fibronectin which is produced by many
cultured cells and differs from the plasma form in having an
extra domain and a correspondingly higher molecular weight.
This was confirmed by immunofluorescence studies in which
a monoclonal antibody specific for the extra domain of cel-
lular fibronectin (F-6140) revealed a network similar to that
in Figure 4a and c in U937A and L929 cultures but not in
U937A/R and L929/R.
The simplest explanation for the failure of 'tight' cells to
have fibronectin in their ECM would be that they fail to
synthesise fibronectin. This is not so as supernatants of
'loose' and 'tight' lines contain approximately equal amounts
of immunoreactive fibronectin on Western blotting. An alter-
native possibility is that there is a qualitative difference in the
secreted fibronectins. In this case, L929/R and U937A/R
should form a fibronectin matrix ifcocultivated with L929 or
U937A. However, after 3 days coculture the 'tight' cells did
not exhibit the network on immunofluorescence with anti-
fibronectin although the 'loose' cells in the same dish did.
Two other lines of evidence also argue against qualitative
differences in the fibronectins. Firstly, there were no major
differences in peptide maps after V8 protease digestion
(Figure 5) and secondly, as shown in the autoradiographs in
Figure 6, the fibronectins all bound to ricin lectin and gelatin
and all failed to bind to wheat germ agglutinin.
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Figure 4 Immunofluorescence of (a) U937A, (b) U937A/R, (c)
L929 and (d) L929/R cells with a polyvalent antiserum raised
against fibronectin. The horizontal line in a indicates 20 iM.
Discussion
The loose colony-forming cell types, L929 and U937A, clearly
have an ECM component which is lacking in their tight
colony forming counterparts, L929/R and U937A/R. The
gelatin-binding ability and immunoreactivity with anti-fibro-
nectin indicate that this component is fibronectin. Fibronec-
tin is highly polymorphic due to alternative mRNA splicing
in different cell types (Hynes, 1985) and although the plasma
form which is derived from the liver has two subunits, each
of 220 kDa molecular weight, the 'cellular' form of fibronec-
tin produced by other cell types often has subunits of
250-300 kDa (Cossu & Warren, 1983; Hedin et al., 1988).
The failure of L929/R and U937A/R cells to incorporate
fibronectin into their ECMs is not due to failure of synthesis
Figure 5 Autoradiograph of V8 protease digests of 35S-methio-
nine-labelled fibronectins from the supernatants of (a) U937A/R,
(b) U937A, (c) L929/R and (d) L929. Digests were analysed by
15% SDS-PAGE and the markers indicate molecular weight
standards, with the values being given in kDa. All samples are
the fibronectin produced by 2.5 x iO1 cells and were mercapto-
ethanol reduced before electrophoresis.
as fibronectin is readily detected in the supernatants of these
cells. There are precedents for this in studies on cell differ-
entiation where there is an accompanying change in fibronec-
tin deposition without a significant change in fibronectin
synthesis (Hassell et al., 1979; Millis et al., 1985; Dahi &
Grabel, 1988). In these systems there is evidence for either
changes in fibronectin structure and/or enhanced ability of
some cell types to incorporate fibronectin into their ECMs.
In our system, one-dimensional peptide mapping revealed no
differences between the fibronectins of cells with and without
networks.
Furthermore, in co-cultivation experiments L929/R and
U937A/R failed to make a fibronectin network when in effect
they were cultured in the presence of fibronectin and other
extracellular products from L929 or U937A, respectively.
These experiments indicate that in terms of fibronectin net-
work formation the defect in L929/R and U937A/R cannot
be at the fibronectin level. Possibly the defect may reside in
the ability of the cells to bind the amino-terminal domain of
fibronectin (Quade & McDonald, 1988). This property is
essential for fibronectin matrix formation and is independent
of the integrin-mediated binding to the Arg-Gly-Asp-Ser, cell
adhesion site of fibronectin (Quade & McDonald, 1988).FIBRONECTIN AND COLONIAL MORPHOLOGY 835
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Figure 6 Autoradiographs of supernatants from 3S-methionine-
labelled cells after binding to wheat germ agglutinin lectin, ricin
lectin or gelatin. The bound material was analysed by 7.5%
SDS-PAGE after mercaptoethanol reduction. In the upper sec-
tion the samples are as follows: a, U937A, wheat germ bound;
b, U937A/R, wheat germ bound; c, U937A, ricin bound; d,
U937A/R, ricin bound; e, U937A, gelatin bound; f, U937A/R,
gelatin bound. In the lower section, the arrangement is the same
except L929 is substituted for U937A and L929/R for U937A/R.
The arrow heads indicate the position of fibronectin. All samples
are the fibronectin produced by 2.5 x 105 cells.
The exact mechanism by which cells move is still unclear
but current models suppose initial attachment of surface
receptors to the extracellular matrix to give the cell anchorage
points to pull or push against with subsequent detachment as
the cell moves forward (Bretscher, 1988). This process must
be dependent on the nature of the ECM and the affinity of
its interaction with the cell. From this it seems reasonable to
assume that the reduced motility of L929/R and U937A/R
relative to L929 and U937A is related to the absence of
fibronectin in their ECMs. In addition we have found that
U937A and U937A/R cells have different glycoforms of a
105 kDa cell surface protein (Neale et al., 1990). This protein
is probably identical to the P2B glycoprotein which is differ-
ently glycosylated in metastatic and non-metastatic cells and
which has differing affinity for fibronectin depending on its
glycosylation state (Dennis, 1988; Laferte & Dennis, 1988).
This protein is not an integrin and it would be intriguing to
know whether it binds fibronectin via the N terminal domain.
In recent studies with melanoma and breast carcinoma cell
lines we have found that the phenomena offibronectin distri-
bution and TNF-susceptibility do not always go together.
Nevertheless, they are associated in U937A and L929 cells
and this begs the question of how the phenomena are related
in these lines. One possibility is that TNF cytolysis and
fibronectin deposition share a common factor or process.
Alternatively the two pathways may be quite separate but
lack of a particular glycosyl transferase in the resistant
mutants results in critical proteins in both pathways being
abnormally glycosylated and malfunctional. With either
model there would also be scope for alternative mutations
such as a mutation within the protein sequence of a critical
protein in the lytic pathway without concomitant effects on
fibronectin deposition. Such a mutation would lead to a
TNF-resistant, motile cell which would retain enhanced
metastatic capacity and the ability to avoid TNF surveil-
lance. Along the same lines, other mutations could affect
fibronectin deposition without loss of TNF susceptibility.
The process of metastasis is complex and the role of
fibronectin deposition is likely to be only one factor and then
limited to particular cell types. For example, while there is
increased fibronectin deposition within metastatic lesions in
Lewis lung cancer in mice (Aoyagi, 1988), in human breast
cancer fibronectin deposition in the tumour stroma inversely
correlates with metastatic potential (Christensen et al., 1988).
This work was supported by the Cancer Research Campaign.
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